Therapeutic implications of germline genetic findings in cancer

Area of Science:

• Genomic Medicine
• Cancer Genomics
• Translational Oncology

Background:

• Cancer genomics traditionally focuses on somatic alterations for personalized therapy targets.
• Germline genome alterations, beyond susceptibility, hold therapeutic information.
• Current analysis algorithms often disregard germline genetics, missing key data.

Purpose of the Study:

• To review the therapeutic potential of germline genome alterations.
• To highlight the need for diversifying biomarker sources in cancer therapy.
• To emphasize the integration of germline data into clinical practice.

Main Methods:

• Literature review of studies on germline genome alterations in cancer therapy.
• Analysis of the role of germline genetics in treatment response and toxicity.
• Examination of current bioinformatic approaches in cancer genomics.

Main Results:

• Germline alterations can predict response to targeted and traditional therapies.
• Germline variants influence anticancer drug toxicities.
• Low actionable yields from somatic testing necessitate exploring germline data.

Conclusions:

• Germline genome analysis is crucial for personalized cancer treatment.
• Integrating germline information can improve therapeutic outcomes and reduce toxicity.
• Enhanced collaboration between oncology and familial risk management is essential.